NYSE:BAX - Baxter International Stock Price, News, & Analysis

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International declared a quarterly dividend on Tuesday, February 19th. Investors of record on Friday, March 1st will be given a dividend of $0.19 per share on Monday, April 1st. This represents a $0.76 dividend on an annualized basis and a yield of 1.00%. The ex-dividend date of this dividend is Thursday, February 28th. View Baxter International's Dividend History.

Baxter International declared that its Board of Directors has approved a stock buyback program on Tuesday, November 13th 2018, which authorizes the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 6.1% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's leadership believes its shares are undervalued.

Baxter International Inc (NYSE:BAX) posted its quarterly earnings data on Thursday, January, 31st. The medical instruments supplier reported $0.78 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.73 by $0.05. The medical instruments supplier had revenue of $2.84 billion for the quarter, compared to the consensus estimate of $2.80 billion. Baxter International had a return on equity of 19.10% and a net margin of 14.60%. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, April 25th 2019. View Earnings Estimates for Baxter International.

Baxter International will be holding an earnings conference call on Thursday, April 25th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8448861929.

Baxter International issued an update on its FY19 earnings guidance on Thursday, January, 31st. The company provided earnings per share guidance of $3.22-3.30 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.27. The company issued revenue guidance of ~$11.1-11.2 billion, compared to the consensus revenue estimate of $11.37 billion.Baxter International also updated its FY 2019 guidance to $3.22-3.30 EPS.

16 equities research analysts have issued 1-year price objectives for Baxter International's stock. Their forecasts range from $70.00 to $89.00. On average, they expect Baxter International's stock price to reach $77.6250 in the next year. This suggests a possible upside of 1.7% from the stock's current price. View Analyst Price Targets for Baxter International.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 4 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

Press coverage about BAX stock has been trending somewhat positive this week, InfoTrie Sentiment reports. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Baxter International earned a news sentiment score of 1.6 on InfoTrie's scale. They also assigned headlines about the medical instruments supplier a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future.

Some companies that are related to Baxter International include 3M (MMM), Stryker (SYK), Becton Dickinson and (BDX), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ResMed (RMD), Teleflex (TFX), ABIOMED (ABMD), DexCom (DXCM), Hill-Rom (HRC), Insulet (PODD), ICU Medical (ICUI), Penumbra (PEN), Globus Medical (GMED) and Integra Lifesciences (IART).

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Johnson & Johnson (JNJ), Honeywell International (HON), Cisco Systems (CSCO), Pfizer (PFE) and Athabasca Oil (ATH).

Baxter International's stock is owned by many different of retail and institutional investors. Top institutional investors include Calamos Advisors LLC (0.22%), Huntington National Bank (0.09%), Gateway Investment Advisers LLC (0.08%), Retirement Systems of Alabama (0.06%), Strs Ohio (0.05%) and Nisa Investment Advisors LLC (0.05%). Company insiders that own Baxter International stock include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including Meeder Asset Management Inc., Palisade Asset Management LLC, Calamos Advisors LLC, Town & Country Bank & Trust CO dba First Bankers Trust CO, Retirement Systems of Alabama, State of Alaska Department of Revenue, BB&T Corp and Gateway Investment Advisers LLC. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was acquired by a variety of institutional investors in the last quarter, including Locust Wood Capital Advisers LLC, Dalton Greiner Hartman Maher & Co., Mercer Global Advisors Inc. ADV, Pacer Advisors Inc., Tibra Equities Europe Ltd, Mercer Global Advisors Inc. ADV, Calamos Wealth Management LLC and Boston Advisors LLC. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $76.34.

Baxter International has a market capitalization of $39.02 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.

The official website for Baxter International is http://www.baxter.com.

Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]